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Abstract
Studying the effects of groups of Single Nucleotide Polymorphisms (SNPs), as in a
gene, genetic pathway, or network, can provide novel insight into complex diseases,
above that which can be gleaned from studying SNPs individually. Common chal-
lenges in set-based genetic association testing include weak effect sizes, correlation
between SNPs in a SNP-set, and scarcity of signals, with single-SNP effects often rang-
ing from extremely sparse to moderately sparse in number. Motivated by these chal-
lenges, we propose the Generalized Berk-Jones (GBJ) test for the association between
a SNP-set and outcome. The GBJ extends the Berk-Jones (BJ) statistic by accounting
for correlation among SNPs, and it provides advantages over the Generalized Higher
Criticism (GHC) test when signals in a SNP-set are moderately sparse. We also pro-
vide an analytic p-value calculation procedure for SNP-sets of any finite size. Using
this p-value calculation, we illustrate that the rejection region for GBJ can be described
as a compromise of those for BJ and GHC. We develop an omnibus statistic as well,
and we show that this omnibus test is robust to the degree of signal sparsity. An
additional advantage of our method is the ability to conduct inference using individ-
ual SNP summary statistics from a genome-wide association study. We evaluate the
finite sample performance of the GBJ though simulation studies and application to
gene-level association analysis of breast cancer risk.
Keywords: Correlated tests; Generalized higher criticism; Omnibus test; Sparse alterna-
tive; Summary statistics.
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1 Introduction
Genome-Wide Association Studies (GWAS) have been successful in identifying the
associations between thousands of Single Nucleotide Polymorphisms (SNPs) and a va-
riety of complex traits (Manolio et al. 2009). A traditional GWAS analysis tests for the
effect of each individual SNP, and this approach has shown that single-SNP effects are of-
ten weak across the genome (Visscher et al. 2012). Recently, set-based tests which jointly
analyze a group of SNPs - e.g. SNPs in a gene, pathway, or network - have become in-
creasingly popular as complementary tools which can boost analysis power in GWAS
(Wu et al. 2010). These tests are also standard for rare variant analysis in whole genome
sequencing studies (Lee et al. 2014).
SNPs can be aggregated into sets based on a variety of genomic features. For exam-
ple, they can be grouped by physical position, such as location in a gene or Linkage Dis-
equilibrium (LD) block, or similar biological functions, such as membership in a genetic
pathway or protein network. Set-based analyses then allow for some natural advantages
over individual SNP methods. Besides reducing the number of multiple comparisons
across the genome, SNP-set methods can increase power by pooling sparse and weak
effects into a stronger aggregated signal, as well as by incorporating biological informa-
tion into the test (Wu et al. 2011). In addition, set-based interpretations of association
may be more meaningful than their single-marker counterparts, such as in a gene-level
or pathway-level analysis.
A number of set-based tests for genetic association studies have been developed in
recent years, including burden tests (Li and Leal 2008), the Sequence Kernel Association
Test (SKAT) (Wu et al. 2011), the minimum p-value test (MinP) (Conneely and Boehnke
2007), and most recently the Generalized Higher Criticism (GHC) (Barnett et al. 2017).
SKAT and burden tests are examples of methods more suitable for detecting dense sig-
nals. If the signals reside in only a few SNPs that are not correlated with noise SNPs, then
the power of SKAT and burden tests will suffer.
While certain SNP-sets may contain a large number of signals, it is more common
that genomic constructs formed with GWAS data will have only a few signal SNPs. In-
terestingly, within tests designed for this sparse alternative setting, there are still subtle
differences in performance. Under extreme sparsity, as in the case of only one or very
few signals in the entire set, the minimum p-value test and the GHC have good power for
detecting a SNP-set effect. However GHC and MinP can lose power under moderate spar-
sity settings, which are relatively common in gene and pathway level analyses of GWAS
data. For example, in the Cancer Genetic Markers of Susceptibility (CGEMS) GWAS for
breast cancer risk (Hunter et al. 2007), four out of 42 SNPs in the FGFR2 gene, a known
breast cancer risk loci, showed strong evidence of association without reaching genome-
wide significance. It is hence of substantial interest to develop testing procedures that can
reliably detect associations across a range of alternatives in the sparse signal regime.
When factors in a set are independent, several goodness-of-fit type methods have
been proposed to perform set-based tests in the presence of sparse signals (Donoho and
Jin 2004; Jager and Wellner 2007; Walther 2013). These methods test for the effect of a set
by aggregating evidence from marginal test statistics, and they have been shown to pos-
sess attractive asymptotic properties when the size of a set goes to infinity. Specifically,
they reach a so-called detection boundary when signals are sparse. In a certain sense, they
are able to detect the weakest signals detectable by any statistical procedure under the
sparse alternative. The class of tests with this ability includes the Higher Criticism (HC)
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(Donoho and Jin 2004) and the Berk-Jones (BJ) (Berk and Jones 1979). Compared to the
HC and BJ tests, the minimum p-value test, for example, is known to attain the detection
boundary over a smaller portion of the sparse regime. In terms of finite sample perfor-
mance, it has been demonstrated through simulation that Berk-Jones outperforms Higher
Criticism over a range of moderately sparse alternatives when marginal test statistics are
independent (Walther 2013; Li and Siegmund 2015). Donoho and Jin (2004) provide an
explanation for this result by showing that HC disproportionately weights evidence from
the most extreme observed marginal test statistic, at the cost of losing sensitivity to detect
signals in other locations.
However, a direct application of BJ to SNP-set testing is not desirable, as standard
p-value calculations for BJ rely on independence between elements in a set (Moscovich-
Eiger and Nadler 2017). This assumption is violated by LD-induced correlation between
neighboring SNPs in a SNP-set. In addition, we will see that even if we correct the in-
ference procedure of the Berk-Jones, the power of BJ can fall dramatically in high LD
settings.
To overcome the challenges posed by correlated SNPs, this paper proposes the Gen-
eralized Berk-Jones (GBJ) statistic for testing the association between a SNP-set and out-
come. GBJ accounts for LD among SNPs in a set while still preserving the ability to detect
moderately sparse and weak signals in finite samples. In fact, GBJ reduces to the Berk-
Jones statistic when all SNPs in a set are independent. GBJ can also be applied to SNP-set
tests using both individual-level genotype data or GWAS summary statistics from single
SNP analysis. To facilitate use, we additionally provide an analytic p-value calculation
for GBJ. Our method is more computationally efficient than permutation and is shown to
be accurate even at the extremely small levels required for genome-wide significance.
Additional insight into the strengths and weaknesses of GBJ is provided by study-
ing the rejection regions of SNP-set tests developed for sparse alternatives. The rejection
regions allow us to quantitatively describe how the power of each test is susceptible to
changes in parameters such as the amount of correlation between SNPs or the size of the
SNP-set. Since in practice we never have knowledge of the type of alternative, we also
propose an omnibus test that combines GBJ, GHC, MinP, and SKAT for added robustness
to different degrees of sparsity. An extensive simulation study demonstrates that GBJ
outperforms alternative methods in testing SNP-set effects when signals are weak and
moderately sparse, and we also show that the omnibus test is robust to a wide range of
sparsity levels.
The remainder of the paper is organized as follows. Section 2 discusses the SNP-
set testing framework using both individual-level data and GWAS summary statistics.
In Section 3 we propose the Generalized Berk-Jones statistic for testing the association
between a SNP-set and outcome. We also provide an analytic p-value calculation for
GBJ and develop the omnibus test. Section 4 compares the rejection regions of GBJ and
other tests designed for the sparse regime. In Section 5 we demonstrate the finite sample
performance of GBJ through simulation. Section 6 presents an analysis of the CGEMS
data, and we conclude with a discussion in Section 7.
2
2 The SNP-Set Testing Framework
2.1 Individual-Level Genotype Data
We begin by describing the SNP-set testing framework using individual-level data
on genotype, outcome, and other covariates for n total subjects. Suppose for subject i,
i = 1, ..., n, we observe the outcome Yi, a genotype vector Gi = (Gi1, ..., Gid)T of d SNPs
in a SNP-set, and a vector of q covariates Xi = (Xi1, ..., Xiq)T . Assume that Yi conditional
on (Gi,Xi) follows a distribution in the exponential family (McCullagh and Nelder 1989)
with the density function f(Yi) = exp {(Yiθi − b(θi))/ai(φ) + c(Yi, φ)}, where a(·), b(·), and
c(·), are known functions, θi is a canonical parameter, and φ is a dispersion parameter. Let
µi = E(Yi|Gi,Xi) denote the conditional mean of Yi and assume it follows the Generalized
Linear Model (GLM)
g(µi) = X
T
i α + G
T
i β,
where g(·) is a differentiable monotone link function. We here only consider canonical
link functions for simplicity. In matrix notation, the data take the form Y = (Y1, ..., Yn)T ,
Gn×d = [ G1, ...,Gn ]
T , and Xn×q = [ X1, ...,Xn ]
T .
The null hypothesis of no association between a SNP-set and outcome, after con-
trolling for covariates, is given by H0 : β = 0. Both the size of the set d and the sparsity of
signals can vary greatly between sets, e.g. from gene to gene, and the number of nonzero
βj is unknown. Our aim is to develop a test suitable for different levels of sparsity while
also accounting for the correlation among individual SNP test statistics.
The marginal score statistic for βj , j = 1, ..., d, is
Zj =
GT.j(Y − µ̂0)√
GT.jPG.j
,
where G.j denotes the jth column vector of G, P = W −WX(XTWX)−1XTW is the
projection matrix, W = diag
{
a1(φ̂)v(µ̂01), ..., an(φ̂)v(µ̂0n)
}
, µ̂0i = g(XTi α̂0), α̂0 is the MLE
of α under the null hypothesis, and v(µi) = b′′(θi) is the variance function.
Under the null, the d marginal score test statistics have an asymptotic multivariate
normal distribution
Z = (Z1, · · · , Zd)T H0∼ N(0d×1,Σd×d),
where Σjj = 1 for all j, and for j 6= k we can estimate
Σ̂jk =
GT.jPG.k√
GT.jPG.j
√
GT.kPG.k
. (1)
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2.2 GWAS Summary Statistics
Many GWAS may not release individual-level data due to logistical challenges or
data confidentiality agreements. Instead it is much more likely that a marginal test statis-
tic for association with the outcome is available for each individual SNP (Pasaniuc and
Price 2016). It is hence of great interest to be able to perform SNP-set testing using pre-
computed Zj from across the genome. To test a set of precomputed Zj with GBJ, we
require estimation of their correlation matrix Σ using external information.
Assume we have a panel of reference genotypes from nr subjects of the same ethnic-
ity as those used to construct the summary statistics. For example, this could come from
the publicly available 1000 Genomes dataset (1000 Genomes Project Consortium 2015).
We estimate Σ using equation (1) but replace G.j and X with G
(r)
.j and X
(r), where G(r).j is
the nr × 1 genotype vector of SNP j from the reference panel, X(r) = (1,PC1, ...,PCm),
PC1, ...,PCm are the first m principal component vectors calculated from the reference
panel, and m is the same number of principal components as was used to control for
population stratification (Price et al. 2006) in the original GWAS analysis of the data. Ad-
ditionally for each subject we estimate v(µ̂0i) by setting µ̂0i equal to the sample mean of
the outcome. For a normally distributed outcome, this is exact as v(·) = 1. For a binary
outcome, since population stratification is the primary confounder of the SNP-outcome
relationship in GWAS, and because µi0 generally varies slowly with the principal com-
ponents, this approximation is practically reasonable. Ultimately we are approximating
GT.jPG.k in (1) by G
(r)T
.j G
(r)
.k − G(r)T.j X(r){X(r)TX(r)}−1X(r)TG(r).k up to a scale parameter,
with the scale parameter eventually cancelled out in Σ̂jk.
3 The Generalized Berk-Jones Test for SNP-Set Effects
3.1 The Berk-Jones Statistic
We briefly review the Berk-Jones statistic in this section to help introduce the Gen-
eralized Berk-Jones statistic in Section 3.2. The BJ statistic is designed to test for H0 :
β = 0 against the alternative that a nonempty subset of the βj are nonzero, assuming the
marginal test statistics are independent. Let Φ¯(t) = 1− Φ(t) denote the survival function
of a standard normal random variable and Φ−1(t) denote its inverse. Let |Z|(j) denote the
order statistics of the vector that results from applying the absolute value operator to each
element of Z, so that |Z|(1) is the smallest value of Z in magnitude.
Set S(t) =
∑d
j=1 1 (|Zj| ≥ t), which is the number of marginal test statistics with a
magnitude greater than or equal to some threshold t. For a fixed t ≥ 0, and if Zj iid∼ N(0, 1)
for all j, then S(t) has a binomial distribution with size d and mean parameter pi = 2Φ¯(t).
This viewpoint motivates the Berk-Jones statistic for independent observations (Donoho
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and Jin 2004) as:
BJd = max
t≥|Z|(d/2+1)
[
S(t) log
{
S(t)
2dΦ¯(t)
}
+ {d− S(t)} log
{
1− S(t)/d
1− 2Φ¯(t)
}]
1
{
2Φ¯(t) <
S(t)
d
}
(2)
= max
1≤j≤d/2
log
Pr
{
S(|Z|(d−j+1)) = j
∣∣∣∣E(Z) = µ̂j,d · Jd}
Pr
{
S(|Z|(d−j+1)) = j
∣∣∣∣E(Z) = 0 · Jd}
1{2Φ¯ (|Z|(d−j+1)) < jd
}
where JTd = (1, 1, ..., 1)1×d, µ̂j,d > 0 solves the equation
j/d = 1− {Φ(|Z|(d−j+1) − µ̂j,d)− Φ(−|Z|(d−j+1) − µ̂j,d)} , (3)
and the second line uses the characterization of S(t) as a binomial random variable.
We see that BJ can roughly be explained as the maximum of a one-sided likelihood
ratio test on the mean parameter of S(t), performed over the larger half of observed test
statistic magnitudes. At t = |Z|(d−j+1) we have pi = 2Φ¯
(|Z|(d−j+1)) under the binomial
likelihood null, and we have pi = j/d under the binomial likelihood alternative. We
say binomial likelihood null and alternative to make clear that we are talking about an
interpretation of the Berk-Jones statistic and to distinguish from the actual set-based null
and alternative hypotheses being tested.
Note that the Higher Criticism test differs from the Berk-Jones by replacing the like-
lihood ratio statistic in (2) with the Pearson Chi-square statistic {S(t)−2dΦ¯(t)}2/{2dΦ¯(t)(1−
2Φ¯(t)}. Let k be the number of causal SNPs in a set. The sparse regime is designated as
k < d1/2, and we call d1/4 < k < d1/2 moderately sparse, with k ≤ d1/4 referred to as
extremely sparse. Donoho and Jin (2004) showed that, when the Zj are all mutually inde-
pendent, both HC and BJ are able to reach the detection boundary over the entire sparse
signal regime as d → ∞. Walther (2013) and Li and Siegmund (2015) showed that the BJ
statistic generally has better power than HC when the size of the set d is finite and the
signals are moderately sparse.
If Z1, ..., Zd are correlated, as they will be for test statistics arising from neighboring
SNPs in a gene, then S(t) no longer has a binomial distribution under the null. In this
case, the standard Berk-Jones statistic no longer has a meaningful interpretation, and we
may expect it to lose efficiency. In fact, we will show later that the rejection region of the
Berk-Jones has a less desirable shape under various correlation structures, leading to a
significant loss in power when the test statistics are not independent. Therefore we are
interested in developing a modified BJ statistic that can account for correlation among the
marginal test statistics in a set and thus possesses rejection regions which are more robust
to arbitrary correlation structures.
3.2 The Generalized Berk-Jones Statistic
We now propose the Generalized Berk-Jones statistic for testing the association be-
tween a SNP-set and outcome. Following the spirit of Berk-Jones, GBJ considers a like-
lihood ratio type statistic on the mean parameter of S(t), but the key difference is GBJ
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explicitly accounts for the correlation structure of Z1, ..., Zd. More precisely, we define the
GBJ statistic as:
GBJd = max
1≤j≤d/2
log
Pr
{
S
(|Z|(d−j+1)) = j∣∣∣∣E(Z) = µ̂j,d · Jd, cov(Z) = Σ}
Pr
{
S
(|Z|(d−j+1)) = j∣∣∣∣E(Z) = 0 · Jd, cov(Z) = Σ}

·1
{
2Φ¯
(|Z|(d−j+1)) < j
d
}
.
When the Zj are correlated, S(t) follows either an underdispersed or overdispersed
binomial distribution instead of the standard binomial. However finding the exact distri-
bution of S(t) when Σ 6= I is difficult. For a general Σ, computing Pr {S(t) = m} requires
iterating through d choose m terms and is very time consuming. In special cases, such as
when Σ has an exchangeable correlation structure with Σ = (1−ρ)I+ρ11T , the calculation
is much easier. However these scenarios occur rarely, if ever, in practice.
We propose to approximate the full distribution of S(t) using an Extended Beta-
Binomial (EBB) distribution (Prentice 1986). The Extended Beta-Binomial is a reparam-
eterization and extension of the standard Beta-Binomial(α, β) distribution with the stan-
dard Beta-Binomial being a special case of the EBB. A random variable V ∼ EBB (d, λ, γ)
has probability mass function
Pr (V = v; d, λ, γ) =
 d
v
 v−1∏
k=0
(λ+ γk)
d−v−1∏
k=0
(1− λ+ γk)
/ d−1∏
k=0
(1 + γk), (4)
where we follow the convention
∏a
k=0 ck = 1 for a < 0. The mean of V is given by
E(V ) = dλ and the variance is Var(V ) = dλ(1− λ) {1 + (d− 1)γ(1 + γ)−1}.
The Extended Beta-Binomial distribution reduces to the Beta-Binomial distribution
if we set λ = α(α+β)−1 and γ = (α+β)−1 for α, β > 0. Because the standard Beta-Binomial
distribution requires α, β > 0, it cannot accommodate underdispersion and never reduces
to the binomial distribution. In contrast, the EBB allows for both overdispersion and un-
derdispersion, and it reduces exactly to the binomial distribution when γ = 0. This mech-
anism allows our GBJ statistic to reduce to the Berk-Jones when there is no correlation
among the observations.
3.3 Calculation of the Generalized Berk-Jones Statistic
We now describe more precisely the mechanics of calculating the GBJ statistic. To
begin, check if the condition 1
{
2Φ¯
(|Z|(d−j+1)) < j/d} is satisfied at any j ≤ d/2. If the
condition is never satisfied, then the observed value of GBJ is 0 and we do not need to
perform any more computation. The following steps should only be taken on indices
j ≤ d/2 where the condition is satisfied.
At each qualifying j, we approximate the distribution of S(|Z|(d−j+1)) by an Ex-
tended Beta-Binomial random variable under both the binomial likelihood null and the
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binomial likelihood alternative. Denote these two variables by V (j)0 ∼ EBB(λ(j)0 , γ(j)0 ) and
V
(j)
a ∼ EBB(λ(j)a , γ(j)a ). We solve for (λ(j)0 , γ(j)0 ) through moment matching equations
λ
(j)
0 = E0
{
S(|Z|(d−j+1))
}
/d,
γ
(j)
0
1 + γ
(j)
0
=
Var0
{
S(|Z|(d−j+1))
}− dλ(j)0 (1− λ(j)0 )
d(d− 1)λ(j)0 (1− λ(j)0 )
,
where E0 and Var0 denote the expectation and variance conditional on Z ∼ MVN(0 ·
Jd,Σ). Similarly, we solve for (λ
(j)
a , γ
(j)
a ) using the same equations except with Ea and
Vara, which are the expectation and variance conditional on Z ∼MVN(µ̂j,d · Jd,Σ).
The first moment matching equation is simple to solve, since clearly
E0
{
S(|Z|(d−j+1))
}
= 2dΦ¯(|Z|(d−j+1)) and Ea
{
S(|Z|(d−j+1))
}
= j. The variance term in
the second equation is more difficult. We can use Theorem 1 of Barnett et al. (2017) for
Var0. For Vara, we need the following theorem:
Theorem 1. Let Z ∼MVN(µ · Jd,Σ), and takeHi(t) be the probabilists’ Hermite polynomials.
Define ρ¯r = 2
d(d−1)
∑
1≤k<l≤d (ρk,l)
r, where ρk,l is the (k, l) element of Σ, and let ρk,k = 1 for all
k = 1, 2, .., d. Then the variance of S(t) is:
Vara {S(t)} = dλ(1− λ) + d(d− 1)
{
φ(t− µ)2
∞∑
r=1
ρ¯r
r!
Hr−1(t− µ)2
}
+d(d− 1)
{
φ(−t− µ)2
∞∑
r=1
ρ¯r
r!
Hr−1(−t− µ)2
}
−2d(d− 1)
{
φ(−t− µ)φ(t− µ)
∞∑
r=1
ρ¯r
r!
Hr−1(−t− µ)Hr−1(t− µ)
}
,
λ = 1− {Φ(t− µ)− Φ(−t− µ)} .
The proof of this theorem is given in the Supplementary Materials. The terms in
the infinite sum shrink very quickly, and in practice we see good accuracy using only the
first ten.
After matching all four parameters (λ(j)0 , γ
(j)
0 , λ
(j)
a , γ
(j)
a ), we calculate
GBJ
(j)
d = log
Pr
(
V
(j)
a = j; d, λ
(j)
a , γ
(j)
a
)
Pr
(
V
(j)
0 = j; d, λ
(j)
0 , γ
(j)
0
)
 .
The maximum value of GBJ (j)d among all qualifying j is then the observed Generalized
Berk-Jones statistic.
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3.4 Analytic P-value Calculation
Let Gd be a general supremum-based global statistic such as the GBJ statistic. Sup-
pose Gd is constructed using independent marginal test statistics Z1, ..., Zd. Denote the
observed value of this statistic by g, where higher values of g indicate more evidence for
the alternative. As noted by Moscovich-Eiger and Nadler (2017), the p-value for g can
often be written
Pr (Gd ≥ g) = 1− Pr
{
∀j = 1, 2, ..., d : |Z|(j) ≤ bj
∣∣∣∣Zj iid∼ N(0, 1)} ,
where 0 ≤ b1 ≤ b2 ≤ ... ≤ bd are ’boundary points’ that come from inversion of the test
statistic. The points b1, b2, ..., bd will depend on g and d and will be different for different
choices of a global statistic, but for the sake of presentation, we will suppress this de-
pendency in the notation. Moscovich-Eiger and Nadler (2017) proposed a method that
can calculate the p-value of Gd very quickly if Z1, ..., Zd are independent. However when
Z1, ..., Zd are correlated, their techniques for a fast calculation are not applicable.
An exact p-value for GBJ, and for any global test applied to correlated observations,
must take into account the covariance structure of Z. The p-value for these tests is then
Pr (Gd ≥ g) = 1− Pr
{
∀j = 1, 2, ..., d : |Z|(j) ≤ bj
∣∣∣∣Z ∼MVN(0,Σ)} , (5)
where bj is understood to additionally depend on Σ as well. We are unaware of any com-
putationally feasible expressions to calculate the joint distribution of the order statistics
|Z|(1), ..., |Z|(d) when d is moderate or large. The Supplementary Materials provides a pro-
cedure to compute this probability by partitioning the region into d! separate sections, but
the method is very computationally intensive and not feasible for use with d > 10.
However, an alternative way to write the rejection region of equation (5) is
Pr
{
∀j : |Z|(j) ≤ bj
∣∣∣∣Z ∼MVN(0,Σ)} = Pr{∀j : S(bj) ≤ (d− j)∣∣∣∣Z ∼MVN(0,Σ)} . (6)
The right hand side of (6) suggests that the quantity can be calculated recursively. Indeed,
define b0 = 0 and qj,a = Pr
{
S(bj) = a,
⋂j−1
k=1 S(bk) ≤ d− k
}
. The quantity in (6) is just qd,0
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and can be calculated recursively as
qj,a =
d−j+1∑
m=a
Pr
{
S(bj) = a, S(bj−1) = m,
j−2⋂
k=1
S(bk) ≤ d− k
}
,
=
d−j+1∑
m=a
Pr
{
S(bj) = a
∣∣∣∣S(bj−1) = m, j−2⋂
k=1
S(bk) ≤ d− k
}
qj−1,m,
≈
d−j+1∑
m=a
Pr
{
S(bj) = a
∣∣∣∣S(bj−1) = m} qj−1,m, (7)
for j > 1, with q1,a = Pr {S(b1) = a|S(b0) = d}. We use an EBB approximation for the
distribution of S(bj) conditional on S(bj−1) = m, with the equations
λj =
Φ¯(bj)
Φ¯(bj−1)
,
γj
1 + γj
=
2
∑
k<l
[
Pr(|Zk|,|Zl|≥bj)
Pr(|Zk|,|Zl|≥bj−1) −
{
Φ¯(bj)
Φ¯(bj−1)
}2]
d(d− 1)λj(1− λj) ,
to match the moments. Finally, set Pr {S(bj) = a|S(bj−1) = m} := Pr (Vj = a) where Vj ∼
EBB(m,λj, γj). Evaluation of Pr (|Zk|, |Zl| ≥ bj) follows from steps similar to the proof of
Theorem 1.
Note that we can generalize the scheme described above to calculate p-values for
many different supremum-based global tests by adopting the general approach of Moscovich-
Eiger and Nadler (2017). As long as the test statistic can be inverted to create the bounds
b1, ..., bd, we can use equation (7) to calculate its p-value when applied to correlated obser-
vations. In particular, we can use this procedure to perform p-value calculations for the
HC, GHC, BJ, and GBJ statistics. Both the calculation and the Generalized Berk-Jones test
are implemented in the R package GBJ, available on the CRAN repository.
3.5 The Omnibus Test
While we will show that the Generalized Berk-Jones test possesses an attractive fi-
nite sample rejection region when signals are moderately sparse, GBJ may also lose power
in the presence of very sparse or dense signals. As SNP-set inference involves testing for
a composite alternative H1 : β 6= 0, there is no uniformly optimal test for both sparse
and dense alternatives. Since signal sparsity varies between genes, the best test will also
change from gene to gene, but it is unknown prior to scanning the genome. Thus we
propose an omnibus test that offers robust power over a range of different sparsity levels.
The omnibus test is constructed by combining the SKAT, GBJ, GHC, and minimum
p-value statistics, which have been described above. The motivation for choosing these
four methods is to combine tests that are known to have good power when signals are
dense, moderately sparse, very sparse, and the sparsest possible, respectively. The MinP
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method uses the set’s largest marginal test statistic in magnitude |Z|(d) as a test statistic.
When the Zj are independent, Donoho and Jin (2004) showed that MinP asymptotically
reaches the same detection boundary as HC and BJ in the very sparse regime k ≤ d1/4 but
not the moderately sparse regime d1/4 < k < d1/2. In finite samples, MinP can have better
power than the other three tests when there are only one or two causal SNPs. In contrast,
SKAT is known to have high power when signals in a SNP-set are dense.
The omnibus test first applies each of the four tests to the same SNP-set, and then
it carries forward the smallest p-value from the four tests as a test statistic. Specifically,
the omnibus test statistic is defined as:
OMNI = min (pGBJ , pGHC , pSKAT , pMinP ) ,
where pGBJ , pGHC , pSKAT , and pMinP denote the p-values of the four tests applied on the
same SNP-set. As these tests are applied to the same data, the four p-values will be
correlated.
Calculations of the p-value for OMNI must again account for the correlation be-
tween tests. We employ a Gaussian copula approximation for the joint distribution of the
inverse-normal transformed p-values:
pOMNI = 1− ΦM
[{
Φ−1(1−OMNI), ...,Φ−1(1−OMNI)}
4×1 ; R4×4
]
,
where ΦM(·; R) denotes the joint cumulative distribution function of a multivariate nor-
mal distribution with mean vector zero and correlation matrix R. The correlation matrix
R of the four component test statistics is estimated through parametric bootstrap under
the null. For each subject i in the study, we simulate a new outcome based on the null
mean µ̂0i. When individual-level data are not available, we take µ̂0i to be the same con-
stant for all subjects as an approximation. Then each of the four tests are applied with the
simulated outcome instead of the original one. The original design matrix, or approxi-
mated design matrix if working with summary statistics, is used each time. Each of the
four p-values is subtracted from 1 and then inverse-normal transformed; under the null
hypothesis the four transformed values have marginal normal distributions with mean
zero. As we only need to estimate the correlation matrix R, only a small number of para-
metric bootstrap samples are needed. In practice, this procedure is repeated 100 times,
and then we set R equal to the sample correlations of the inverse-normal transformed
statistics. We will see that this omnibus test performs well across a variety of settings.
4 Rejection Region Analysis of Different SNP-Set Tests
We study in this section the finite sample rejection regions for the BJ, GBJ, HC, and
GHC tests, and we advocate for viewing these statistics as boundary-defining algorithms.
Consider a fixed SNP-set swith size d = ds and correlation structure Σ = Σs, and suppose
we wish to conduct inference at level α = 0.01. Using the p-value calculation from above,
we can employ standard root-finding routines to find the observed value gs which would
result in a GBJ p-value of 0.01 for a SNP-set with these characteristics. Then inverting gs
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to find boundary points b1, b2, ..., bds as in Section 3.4 constructs a rejection region in terms
of in terms of |Z|(1), ..., |Z|(ds). That is, if the observed value of |Z|(j) were larger than bj
for any j = 1, 2, ..., ds, then the GBJ p-value for this set would be less than 0.01. Plotting
the bounds for various tests using different values of α, d, and Σ shows us exactly what
types of signals a given test is well-powered to detect at level α. For the same setting, a
test with smaller bounds is preferred, as it will provide more finite sample power.
To numerically compare the rejection boundaries, consider a simplified model of
SNP-set correlation structure where the set is partitioned into only two sections. Let one
section be the independence section, where all SNPs in this portion are completely inde-
pendent of all other SNPs in the set. Let the other section be the correlated section, where
all SNPs in this portion have common pairwise correlation ρ with other SNPs in the sec-
tion. For our numerical study, ρ = 0.3 for the correlated section. We investigate SNP-sets
of size d = 20 and 100, correlated sections which contain 50% and 75% of the SNPs, and
tests at size α = 0.01. These parameters are chosen to represent reasonable boundaries
on the correlation structures seen in common GWAS data; Dawson et al. (2002) estimated
that the average r2 between SNPs separated by 100kb is around 0.1.
The rejection regions for each SNP-set are plotted in Figure 1. At the jth coordinate
on the x-axis, if the observed |Z|(j) lies above the boundary of a particular test at that
coordinate, then we would reject the null for that test at level α = 0.01. The lines on the
graph are added to aid in visualization, but there should be no interpretation of interpo-
lation between the points. It does not make sense to think of the boundary at |Z|(2.5), for
example. While standard methods for inference on HC and BJ are invalid in the presence
of correlation, valid p-values for these tests can be computed with the same ideas we have
introduced for GBJ inference, specifically following equations (5)-(7). Thus we can show
that HC and BJ sometimes have much less desirable rejection regions when SNPs in a set
are correlated.
One of the clearest trends from Figure 1 is that the HC and GHC boundaries are
lower for a small region around |Z|(d), and then the BJ and GBJ boundaries quickly be-
come smaller as we move left. This behavior indicates that HC and GHC are better at
detecting the sparsest alternatives with only a very few signals, as those signals would
almost always manifest as the test statistics with the largest magnitude. In contrast, the
plots demonstrate that BJ and GBJ can have more power to detect weaker, less sparse sig-
nals which may be more easily found by examining the test statistic which is, say, fifth or
tenth largest in magnitude. The boundaries of HC and GHC can drop below BJ and GBJ
again for the smallest observed magnitudes, but signals would only be found in these
observations if they are particularly dense, a setting which is not the focus of our efforts.
The intuition we can glean from this figure is closely aligned with the theoretical devel-
opment of Donoho and Jin (2004) and the simulations of Li and Siegmund (2015) when
the marginal test statistics Zj are independent. These authors showed that HC is attuned
to detect sparse signals arising at the very tail of the observed distribution, while BJ has
more power as the number of signals rises.
These results also show why BJ is likely to have low power for detecting sparse
signals when the level of correlation is high. When 75% of the SNPs are correlated, the
rejection boundary for BJ at the largest few observations is the highest by multiple orders
of magnitude on the p-value scale. It would not be desirable to apply BJ in these types of
settings, as the test loses an extremely large amount of sensitivity to detect signals in the
most outlying values. BJ is still likely to be suitable for detecting dense signals in these
situations. Here, GBJ acts as a compromise between BJ and GHC under high correlation.
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Figure 1: Rejection region of Berk-Jones, Generalized Berk-Jones, Higher Criticism, and
Generalized Higher Criticism tests, plotted according to the order statistics of the absolute
values of the test statistics. If the jth smallest test statistic in magnitude is greater than
the boundary point for a given test at any point j on the x-axis, then we would reject the
null using that test at level α = 0.01. The difference between BJ and GBJ becomes much
more pronounced as both the size of the set and the amount of correlation increase.
GBJ provides a much lower boundary than BJ at the tail in exchange for slightly higher
boundaries near the middle. Thus, GBJ can detect both sparse and dense signals in this
example. On the other hand, GBJ provides a slightly higher boundary than GHC at the tail
in exchange for lower boundaries past the tail, so it trades some power in the extremely
sparse regime for more power to detect moderately sparse signals.
We see that choosing a different statistic is essentially choosing a different boundary-
setting algorithm, and this choice should ideally be informed by parameters such as the
amount of correlation and estimated sparsity level. Ultimately these plots illustrate that
there is no single best global test for all types of alternatives. A genome-wide analysis
strategy using the omnibus test will be likely to have robust power across different spar-
sity settings, correlation structures, and SNP-set sizes.
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5 Simulation Results
5.1 Type I Error of the Generalized Berk-Jones Test
We first illustrate that our p-value calculations for the GBJ and omnibus tests are
accurate enough to control the Type I error rate at levels required to declare genome-
wide significance of a SNP-set. To replicate the setting of traditional GWAS data, we
perform the size simulation on random regions across chromosome 5 which correspond
to known gene sizes. We also conduct the size simulation on a high-LD subset of the
FGFR2 gene and a low-LD subset of the FGFR2 gene to parse LD-related effects. We
choose FGFR2 because it contains both high and low LD regions, and because it will later
be the most significant gene in our analysis of the CGEMS data. All SNP-sets contain
genotypes simulated with HAPGEN2 (Su et al. 2011) using the CEU population from
HapMap3 as a reference panel.
In all simulations the outcome is generated as Y ∼ N(0, 1), and we fit the linear
regression model (1) with β = 0 and Xi = 1. Each simulation is repeated 20 million times,
and we report the Type I error down to 10−5. Table 1 shows that our GBJ p-value calcula-
tion is accurate and protects the correct size for correlation structures seen in actual data.
The p-value calculation for the omnibus test is similarly accurate at the most stringent
significance levels, but it is somewhat conservative at larger significance levels.
Table 1: Type I error of GBJ computed over 20 million simulations. The strong LD setting
denoted by SLD refers to eight SNPs from FGFR2 which are highly correlated. The weak
LD setting denoted by WLD refers to eight SNPs from FGFR2 which demonstrate only a
small amount of correlation with each other. The Chr5 setting refers to over 500 regions
on chromosome 5 corresponding to known gene sizes.
Nominal α GBJ, WLD GBJ, SLD GBJ, Chr5 OMNI, WLD OMNI, SLD OMNI, Chr5
1 · 10−2 9.65 · 10−3 8.50 · 10−3 9.35 · 10−3 7.22 · 10−3 6.88 · 10−3 6.74 · 10−3
1 · 10−3 9.70 · 10−4 9.21 · 10−4 1.06 · 10−3 6.95 · 10−4 7.19 · 10−4 6.90 · 10−4
1 · 10−4 9.82 · 10−5 9.90 · 10−5 1.20 · 10−4 7.70 · 10−5 9.00 · 10−5 8.06 · 10−5
1 · 10−5 9.65 · 10−6 1.11 · 10−5 1.49 · 10−5 9.35 · 10−6 1.31 · 10−5 1.08 · 10−5
5.2 Power of GBJ Under Varying Hypothetical Correlation Structures
and Sparsity Settings
To study the power of GBJ, we first conduct simulations under a variety of hypo-
thetical correlation structures and sparsity settings. The performance of the GBJ is com-
pared to the minimum p-value test, GHC, SKAT, and the omnibus test described in Sec-
tion 3.5. The MinP test p-value is calculated by casting MinP as a boundary-defining test
with bj = |Z|(d) for all j, and then computation proceeds through the methods described
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in Section 3.4. GBJ and GHC similarly use the p-value calculation described above. For
SKAT, we run the corresponding R package.
To study how power is impacted by different correlation structures between the
SNPs, we utilize block correlation structures which are slightly more complex than those
used for the rejection region analysis in Section 4. Specifically, consider a set of causal
SNPs that are correlated amongst themselves with common pairwise correlation ρ1. All
other SNPs are then non-causal, and we allow half of them to have an exchangeable corre-
lation structure with correlation ρ3; the other half of the non-causal SNPs are completely
independent of all other non-causal SNPs. Finally the pairwise correlation between a
causal SNP and a non-causal SNP is set at ρ2. The three correlations ρ1, ρ2, ρ3 will vary
between 0 and 0.3. All SNPs are generated to have minor allele frequency of 0.3.
We demonstrate the effects of signal sparsity by using a large SNP-set of d=100
SNPs and varying the number of causal SNPs from k = 1 to k = 10. This allows us
to examine power profiles in the very sparse regime (one to three causal SNPs), in the
moderately sparse regime (four to nine causal SNPs), and at the edge of the dense regime
(ten or more causal SNPs). The true disease model is
Yi =
k∑
j=1
βjGij + i, i ∼ N(0, 1), (8)
where all the βj are the same and depend on the number of causal SNPs k. We reduce
βj slightly as k increases in order to keep the power of each test below one throughout
the entire sparse regime. The full details on effect size for each simulation are available
in the Supplementary Materials. Figure 2 considers the case where the noise SNPs are
independent, and Figure 3 considers the case where the noise SNPs are correlated. We
perform 500 simulations at each different value of k and test at α = 0.01. All the power
curves are smoothed to show empirical power.
The first significant trend appearing in Figure 2 is the effect of sparsity on power.
Among the non-omnibus tests, we see that GHC and MinP perform well when the num-
ber of causal SNPs is low, as these tests often have the most power in the very sparse
regime. In both panels of Figure 2, the transition to GBJ having more power than GHC
and minP occurs in the moderately sparse regime. Then as the number of causal SNPs
increases into the dense regime, SKAT begins to catch up and eventually becomes the
most powerful test. This behavior matches our intuition as well as previously published
simulation results. GHC and minimum p-value place excess weight on the most outlying
observations, so they are well-tuned to detect the very sparse signals. The rejection region
of GBJ is better-suited to find moderately sparse signals, and SKAT is known to perform
well with dense signals.
The relationship between sparsity and power can be modified by the total amount
of correlation. In the left panel of Figure 3 we set ρ1 = ρ3 = 0.3, which corresponds to
the situation where causal SNPs and non-causal SNPs are correlated within themselves,
but the two groups are independent of each other. In this case, MinP and GHC become
the top-performing tests for a larger range of sparsity settings, with GBJ losing some
of its advantage in the moderately sparse regime. SKAT has almost no power in these
situations, as the signals are sparse and there is no correlation between causal and non-
causal SNPs. It appears that a large amount of correlation between the non-causal SNPs
is detrimental to the performance of GBJ. An explanation for this behavior can be found
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Figure 2: Power of set-based tests when noise SNPs are independent. On the left, all SNPs
are completely independent of each other. On the right, causal SNPs are correlated within
themselves at ρ1 = 0.3. As the number of causal SNPs increases, we slightly decrease the
effect size to keep power bounded away from one.
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Figure 3: Power of set-based tests when there is correlation within noise SNPs (left) and
across all SNPs (right). The correlation structure on the right is slightly simpler than the
previous three structures, as we switch to an exchangeable correlation matrix in order to
accommodate ρ2 = 0.3 while still ensuring the correlation matrix is positive definite. As
the number of causal SNPs increases, we decrease the effect size to keep power bounded
away from one.
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in the rejection region analysis of Figure 1. We see that the bounds of GBJ appear less
favorable compared to GHC when the amount of correlation is high. Since over half of
the SNPs in Figure 3 are correlated with ρ1 = ρ3 = 0.3, these settings represent a much
larger amount of total correlation than was present in Figure 2.
In the right panel of Figure 3 we investigate the setting of ρ2 6= 0 by using an
exchangeable correlation structure, and SKAT dominates as the most powerful test across
almost all sparsity levels. Here we break slightly from the above framework by using
exchangeable correlation to accommodate ρ2 = 0.3 while still ensuring the correlation
matrix of the SNPs is positive definite. GBJ is a close second to SKAT under most sparsity
settings with these parameters. SKAT is known to have good performance in the presence
of LD between causal SNPs and noise SNPs, which makes signals appear to be dense.
The increased density of signals also buoys the performance of GBJ compared to GHC
and minimum p-value, which perform the worst under exchangeable correlation.
Never losing too much power compared to the best test, the omnibus test appears
to be robust to LD structure and sparsity. This behavior is expected as our omnibus ap-
proach integrates information from tests which perform well across multiple sparsity set-
tings. Thus we would anticipate that OMNI is more resilient than any single test.
GBJ also demonstrates good power in a variety of situations, and its overall strength
and robustness across the entire sparse regime are attractive properties. In particular, GBJ
is the best-performing test when the level of sparsity is moderate and there is weak corre-
lation among the noise SNPs. GBJ is disadvantaged against minP and GHC when signals
are extremely sparse or there is excess correlation among noise SNPs, but it outperforms
these tests as signals become more dense. In contrast, GBJ provides slightly less power
than SKAT as signals reach the dense regime or when there is moderate correlation be-
tween causal and non-causal SNPs, but GBJ is also much more robust than SKAT when
signals are sparse and not correlated with noise SNPs. Similar to OMNI, GBJ does not fall
far behind the best test in any given situation, which suggests that GBJ is a good choice to
use when the signal sparsity is unknown. Power for the standard BJ is not plotted in the
interest of space, but it behaves like a dense test, similar to SKAT, under correlation. This
behavior again matches Figure 1, which showed that BJ is more suited to detect dense
signals as the amount of correlation increases.
5.3 Power of GBJ under Actual Chromosome 5 Correlation Structures
We conduct one final simulation to investigate the power of Generalized Berk-Jones
under the unstructured LD patterns found in real GWAS data. In this simulation, we
choose blocks of 40 SNPs at random locations on chromosome 5, and then genotype data
are generated using HAPGEN2. We choose 40 to again approximately match the charac-
teristics of FGFR2. There are 2000 blocks chosen for each sparsity level, and 10 simulations
are performed on each block, for a total of 20000 at each number of causal SNPs. Again,
the effect size is decreased as the number of causal SNPs increases, with the outcome still
generated from equation (8). Testing is performed at α = 1 · 10−5 to mimic a practical
analysis.
We see in the left panel of Figure 4 that GBJ, GHC, and the omnibus test all have
very similar power curves in this setting, while SKAT and minP lag slightly behind.
As the number of causal SNPs increases, GBJ demonstrates the best power by a small
amount. These results are rather homogenous because sparsity levels are more coarse
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Figure 4: Power of set-based tests with correlation structures found in actual chromo-
some 5 data. Left panel presents all simulations and right panel shows only SNP-sets
where median |ρ3| < 0.1. The effect size begins at βj = 0.16 and falls to βj = 0.1 so
that power remains below one as the number of causal SNPs increases. GBJ is the best-
performing test in both panels as the number of causal SNPs increases.
and because the parameters are a mix of the values defined in Figures 2 and 3.
Recall that GBJ extended its advantage over GHC when there was less correla-
tion among noise SNPs. When restricting our analysis to the blocks which have median
|ρ3| < 0.1, we see a more substantial superiority of GBJ over GHC in the moderately
sparse regime, similar to Figure 2. Thus it is possible to recover the patterns of the struc-
tured simulation in real genotype data. Obviously median |ρ3| is not a perfect summary
measure, as it cannot single-handedly capture all the parameters in a 40 × 40 correlation
matrix. Further parsing of the data would be necessary to see larger differences in per-
formance. In a practical setting, we might switch between tests based on certain SNP-set
characteristics, such as applying GBJ when the set is large and likely to have moderately
sparse signals. These results do again demonstrate the robustness of GBJ across multiple
situations, as it provides the most power across a large portion of the sparse regime.
6 Gene-Level Analysis of the CGEMS GWAS Data
The CGEMS breast cancer dataset contains a case-control sample of 1145 breast
cancer cases, all postmenopausal women with European ancestry, and 1142 controls re-
cruited from the Nurses’ Health Study. These women were genotyped at approximately
550000 SNPs with the Illumina HumanHap500 array. The dataset was originally analyzed
by Hunter et al. (2007) in the single-marker GWAS approach. The authors did not find any
individual SNPs to reach the genome-wide significance level of 5 × 10−8, but they high-
lighted FGFR2 as a strong candidate for future studies based on four SNPs in the gene
that showed suggestive association with breast cancer. Such a situation succinctly illus-
trates the burden of adjusting for multiple comparisons when testing individual SNPs.
Gene-level analysis provides an attractive alternative strategy that can reduce the num-
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ber of comparisons and also aggregate evidence of signals across multiple SNPs in a gene.
Here we perform a gene-level analysis to study the association between genes and breast
cancer risk.
Since individual-level genotype data were available for this study, we first calcu-
lated the marginal test statistics for each SNP using the model in Section 2.1. Specifically,
we fit a logistic regression model with four covariates - age and the first three genotype
principal components to control for population structure (Price et al. 2006). Then, for each
of 14991 genes, we collected the marginal test statistics for all SNPs located within the re-
gion defined by that gene. Each gene with more than one marginal SNP test statistic was
analyzed with GBJ, GHC, SKAT, MinP, and the omnibus test.
In Table 2, we rank the top ten genes according to the smallest p-value produced
by any of the five tests. In this sample, GBJ provides the strongest evidence of association
for the top four genes and five of the top ten. Most of these genes are ranked highly by
multiple other methods, however no other method provides the lowest p-value for more
than two of the top ten genes. In fact, GHC and MinP produce the smallest p-value only
once between the two of them. One possible explanation for the underperformance of
GHC and MinP is that there may be multiple tagged SNPs surrounding the true causal
loci for each of these genes, which could create a lack of extremely sparse alternatives.
Table 2: Top significant genes in gene-level analysis of CGEMS breast cancer GWAS data,
ranked by minimum p-value produced by any of the five tests. The test which produces
the smallest p-value for each gene is highlighted in red.
Gene GHC GBJ MinP SKAT OMNI d
FGFR2 2.84 · 10−5 4.58 · 10−6 8.20 · 10−5 3.32 · 10−5 2.58 · 10−5 35
CNGA3 3.00 · 10−4 4.04 · 10−5 1.75 · 10−3 8.34 · 10−5 1.84 · 10−4 26
PTCD3 1.21 · 10−4 5.50 · 10−5 3.16 · 10−4 1.87 · 10−4 6.83 · 10−5 12
POLR1A 9.58 · 10−5 6.19 · 10−5 4.62 · 10−4 4.23 · 10−4 3.87 · 10−4 17
ZNF263 4.89 · 10−4 3.90 · 10−4 8.09 · 10−4 1.26 · 10−3 6.84 · 10−5 3
VWA3B 4.20 · 10−4 2.32 · 10−4 1.43 · 10−3 1.48 · 10−4 4.87 · 10−4 51
TBK1 7.04 · 10−4 3.35 · 10−4 1.27 · 10−3 1.48 · 10−4 6.05 · 10−4 11
ABCA1 3.74 · 10−3 1.65 · 10−4 7.92 · 10−3 4.99 · 10−4 2.26 · 10−4 63
MMRN1 2.31 · 10−4 5.51 · 10−4 1.72 · 10−4 3.34 · 10−2 7.73 · 10−4 10
TIGD7 5.79 · 10−4 3.78 · 10−4 1.32 · 10−3 1.33 · 10−3 2.05 · 10−4 4
The lowest p-value for any gene over all five tests is produced by testing FGFR2
with GBJ, supporting the conclusions of Hunter et al. (2007). Since FGFR2 appears to
have signals coming from at least four different SNPs and contains 35 SNPs in total, it
would seem to fall into the category of moderate signal sparsity, where GBJ has good per-
formance. Thus we may have expected beforehand that GBJ would be the most powerful
test for this gene. FGFR2 has been further validated as a breast cancer associated locus in
multiple follow-up studies (Meyer et al. 2008; Liang et al. 2008).
Besides FGFR2, genes such as PTCD3 and POLR1A have also been implicated as
risk loci in independent investigations (Boehm et al. 2007; Jia et al. 2011). The overlap
of our findings with other studies and other statistics provides a level of reassurance
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that GBJ performs well in identifying truly significant genes and not simply spurious
associations. Alternately, ABCA1 is an example of a gene that may not have received
further scrutiny if we were not utilizing the GBJ test. ABCA1 expression has been linked
with breast cancer risk (Smith and Land 2012), but MinP and GHC do not provide the
same strength of evidence that GBJ does. It seems likely that there are more than a few
signal SNPs in ABCA1, especially since ABCA1 contains a relatively large number of
SNPs compared to the other genes in this dataset.
Perhaps due to the limited sample size, no test produces a p-value low enough
to be declared significant after Bonferroni correction for 14991 genes. Still, this analysis
highlights the advantages of Generalized Berk-Jones compared to alternative tests. The
GBJ p-value for FGFR2 does come very close to the Bonferroni-corrected level (3.34 ×
10−6), and it certainly provides more evidence of association than the single SNP statistics.
Additionally, GBJ often gives the highest measure of significance, and never the lowest,
in the genes displayed, demonstrating its robustness across different set sizes and LD
patterns.
7 Discussion
We have proposed the Generalized Berk-Jones statistic to test for association be-
tween a SNP-set and an outcome. Our GBJ generalizes the standard Berk-Jones by mod-
ifying the BJ statistic to directly account for the correlation between individual SNPs.
This modification results in a test that is more powerful when SNPs are in LD. We also
provide an analytic p-value calculation for GBJ and generalize it to a class of supremum-
based global tests, allowing valid inference for HC, GHC, BJ, and other methods when
these procedures are applied as SNP-set tests using correlated marginal test statistics. Re-
jection region analysis demonstrates that GBJ can be described as a compromise between
Berk-Jones and Higher Criticism-type tests in terms of finite sample performance.
While our numerical analysis shows situations where GBJ does not set the lowest
boundary at either |Z|(d) or |Z|(d/2), GBJ generally comes very close to the lowest boundary
at both locations, which affords it both robustness to signal sparsity and power to detect
moderately sparse signals. GHC and HC often set the lowest boundary around |Z|(d),
but in return they concede a large amount of volume past the first few most extreme
observations, which lowers power in the moderately sparse regime. BJ frequently sets
the lowest boundary past the tail, but its tail boundary can be orders of magnitude larger
than that of GBJ, HC, and GHC. Bounds in the expected signal regions must be viewed
holistically, so slightly lower bounds at a few locations are not necessarily desirable if the
price is much higher bounds in other signal locations, as in the case of BJ. Thus GBJ offers
good power to detect moderately sparse effects without losing too much power when
single-SNP signals are extremely sparse.
Simulation results reinforce the conclusions we find from examining the rejection
regions of GHC and GBJ. Additionally we see that the MinP test performance is quite
good when signals are very sparse, similar to GHC, but MinP does not perform as well
as GHC when signals become more dense. SKAT has a unique power profile, as it can be
particularly powerful when signals are dense or there is correlation between causal and
non-causal SNPs, but it is also not robust to different correlation structures and will often
have very little power in sparse settings where there is no correlation between causal and
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non-causal SNPs. The omnibus test offers robust power across different sparsity levels,
and while it is rarely the best test, it also never has the worst power. When applied to data
from the CGEMS study, we see that GBJ often produces the most significant p-values,
perhaps owing to its versatility across different parameter settings.
In demonstrating that the BJ statistic can be adapted for increased robustness to
correlation, we have also demonstrated that these types of boundary-defining algorithms
can be modified to increase finite sample power under specific set-level parameters. It
would be of interest to develop different boundary-defining methods that offer more fa-
vorable rejection regions in narrow but well-defined settings. For example, it may be
possible to define tests which outperform GHC or minP over finer partitions of the ex-
tremely sparse regime.
In a similar vein, it would be interesting to understand the boundary shapes for
other previously proposed boundary algorithms (Jager and Wellner 2007) in the class
of Berk-Jones and Higher Criticism. While many of these algorithms share the same
asymptotic guarantees of BJ and HC, little is known about their comparative finite sample
performance, especially when observations in a set are correlated. These other methods
might also have great value in specific settings as mentioned above. It would additionally
be very valuable to develop SNP-set tests that are optimal in certain senses for arbitrary
sparsity and correlation.
As genomic data collection techniques continue to evolve, it may be necessary to
adapt the GBJ as well. In particular, the rise of whole genome sequencing and fine map-
ping studies is leading to the discovery of more SNPs with extremely rare minor alleles.
Marginal test statistics generated from these SNPs are known to be non-Gaussian in finite
samples, and thus they will not have the distribution we assume for GBJ. GBJ will need
to account for null distributions that are not standard normal before SNP-sets containing
rare variants can be tested.
SUPPLEMENTARYMATERIAL
The supplementary materials provide the proof of Theorem 1 from Section 3.3, offer
further details on how to calculate the exact p-value from equation (5) in Section 3.4, and
list the exact simulation parameters from Section 5.
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